Impact of the National Drug Price Negotiation policy on the price, usage, and affordability of anticancer medicines in Shandong Province, China.

Front Public Health · 2024 · PMC11747042 · PMID 39839411

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The use of 10 other drugs showed a trend of increasing and then decreasing, the largest decrease from 2021 to 2022 is 44.72% for Crizotinib and the smallest is 0.91% for Afatinib.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.